Androgen deprivation therapy increases the sensitivity of human prostate carcinoma cells to T cell-mediated lysis through an androgen receptor dependent mechanism

Ähnliche Einträge

• Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
  von: Ardiani, Andressa, et al.
  Veröffentlicht: (2014)
• Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin
  von: Kwilas, Anna R., et al.
  Veröffentlicht: (2016)
• Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy
  von: Kwilas, Anna R, et al.
  Veröffentlicht: (2015)
• Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
  von: Kwilas, Anna R, et al.
  Veröffentlicht: (2014)
• Attacking malignant cells that survive therapy: Exploiting immunogenic modulation
  von: Hodge, James W, et al.
  Veröffentlicht: (2013)